Demand for the drug, a first generation GLP-1, has been falling with the loss of patent protection last year and as patients move to more effective and once-weekly treatments such as Novo Nordisks Ozempic and Eli Lillys Mounjaro
It binds the CJC-1295 (No DAC) GHRH receptor on pituitary somatotrophs and stimulates the synthesis and release of growth hormone
"We realized there was more to the drug than just sugar control and weight loss." Malhotra said she believes many people can safely microdose GLP-1s, but she cautions against the following common mistakes
An Anti-Inflammatory Diet: We often recommend a Mediterranean-style way of eating, rich in colourful vegetables, fruits, nuts, seeds, extra virgin olive oil, and oily fish
Retatrutide is an investigational triple GIP/GLP-1/glucagon receptor agonist and currently provides the strongest clinical support for the glucagon paradox